Jordan M Kraaijenhof

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Low Density Lipoprotein

Dna Methylation

Cardiovascular Disease

Top Venues

Journal of the American Heart Association

European heart journal

Expert review of clinical immunology

Circulation. Genomic and precision medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Nick S Nurmohamed, Evangelos Tzolos, Mohammed Nooruddin Meah, Jolien Geers, Yannick Kaiser, Jeffrey Kroon, G Kees Hovingh, Erik S G Stroes, Marc R Dweck
Interleukin 6 plasma levels are associated with progression of coronary plaques. Open heart 11 (2) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Jordan M Kraaijenhof, Héléne Toinét Cronjé, G Kees Kornelis Hovingh, Nick S Nurmohamed, Dipender Gill, Loukas Zagkos
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition. Journal of the American Heart Association 13 (12) (2024)
Nick S Nurmohamed, Jordan M Kraaijenhof, Manuel Mayr, Stephen J Nicholls, Wolfgang Koenig, Alberico Luigi Catapano, Erik S G Stroes
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. European heart journal (2023)
Jordan M Kraaijenhof, Tjerk S J Opstal, Jan-Hein Cornel, Dipender Gill, G Kees Kornelis Hovingh, Alberico Luigi Catapano, Wolfgang Koenig, Paul M Ridker, Erik S G Stroes, Nick S Nurmohamed
Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy. Arteriosclerosis, thrombosis, and vascular biology (2023)
Jordan M Kraaijenhof, Tycho R Tromp, Nick S Nurmohamed, Laurens F Reeskamp, Marije Langenkamp, Johannes H M Levels, S Matthijs Boekholdt, Nicholas J Wareham, Menno Hoekstra, Erik S G Stroes, G Kees Kornelis Hovingh, Aldo Grefhorst
ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity. Journal of the American Heart Association (2023)
Nick S Nurmohamed, Jordan M Kraaijenhof, Erik S G Stroes
Different inflammatory pathways underlying cardiovascular risk in secondary prevention. European heart journal 43 (38) (2022)
Nick S Nurmohamed, João P Belo Pereira, Renate M Hoogeveen, Jeffrey Kroon, Jordan M Kraaijenhof, Farahnaz Waissi, Nathalie Timmerman, Michiel J Bom, Imo E Hoefer, Paul Knaapen, Alberico Luigi Catapano, Wolfgang Koenig, Dominique P V de Kleijn, Frank L J Visseren, Evgeni Levin, Erik S G Stroes
Targeted proteomics improves cardiovascular risk prediction in secondary prevention. European heart journal 43 (16) (2022)
Frederik Flindt Kreiner, Jordan M Kraaijenhof, Matthias von Herrath, G Kees Kornelis Hovingh, Bernt Johan von Scholten
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives. Expert review of clinical immunology 18 (4) (2022)
Arjen J Cupido, Jordan M Kraaijenhof, Stephen Burgess, Folkert W. Asselbergs, G Kees Kornelis Hovingh, Dipender Gill
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization. Circulation. Genomic and precision medicine 15 (1) (2022)